Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Haefliger

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Communications Biology|December 20, 2024
A deep learning framework deploying segment anything to detect pan-cancer mitotic figures from haematoxylin and eosin-stained slidesZhuoyan Shen, Mikaël Simard, Douglas Brand, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2024
TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)Ilaria Colombo, Kira-Lee Koster, Lisa Holer, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2024
Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trialAnna M Mc Laughlin, Dagmar Hess, Robin Michelet, et al.
Clinical Pharmacokinetics|November 18, 2025
TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16)Marian Klose, Ilaria Colombo, Katrin Gobat, et al.
Cell Reports. Medicine|June 18, 2025
A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastomaJuanita Suzanne Lopez, Simon Haefliger, Ruth Plummer, et al.
Cell Genomics|February 13, 2023
Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilitiesRoberta Esposito, Taisia Polidori, Dominik F Meise, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 25, 2025
Classification of Fibro-Osseous Tumors in the Craniofacial Bones Using DNA Methylation and Copy Number AlterationsTony G Kleijn, Baptiste Ameline, Willem H Schreuder, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Communications Biology|December 20, 2024
A deep learning framework deploying segment anything to detect pan-cancer mitotic figures from haematoxylin and eosin-stained slidesZhuoyan Shen, Mikaël Simard, Douglas Brand, et al.
European Journal of Cancer (Oxford, England : 1990)|February 20, 2024
TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)Ilaria Colombo, Kira-Lee Koster, Lisa Holer, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2024
Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trialAnna M Mc Laughlin, Dagmar Hess, Robin Michelet, et al.
Clinical Pharmacokinetics|November 18, 2025
TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16)Marian Klose, Ilaria Colombo, Katrin Gobat, et al.
Cell Reports. Medicine|June 18, 2025
A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastomaJuanita Suzanne Lopez, Simon Haefliger, Ruth Plummer, et al.
Cell Genomics|February 13, 2023
Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilitiesRoberta Esposito, Taisia Polidori, Dominik F Meise, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 25, 2025
Classification of Fibro-Osseous Tumors in the Craniofacial Bones Using DNA Methylation and Copy Number AlterationsTony G Kleijn, Baptiste Ameline, Willem H Schreuder, et al.
Pageof 5